Evelyn Mei Huang

Array ( [id] => 7315009 [patent_doc_number] => 20040034221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Aza-and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors' [patent_app_type] => new [patent_app_number] => 10/399083 [patent_app_country] => US [patent_app_date] => 2003-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26274 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20040034221.pdf [firstpage_image] =>[orig_patent_app_number] => 10399083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1425618 [patent_doc_number] => 06503923 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-07 [patent_title] => 'Haloalkoxy imidazonaphthyridines' [patent_app_type] => B1 [patent_app_number] => 09/926267 [patent_app_country] => US [patent_app_date] => 2001-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4877 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 283 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/503/06503923.pdf [firstpage_image] =>[orig_patent_app_number] => 09926267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6381787 [patent_doc_number] => 20020119991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Anticholinergics, processes for preparing them, and pharmaceutical compositions containing them' [patent_app_type] => new [patent_app_number] => 09/965766 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16706 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119991.pdf [firstpage_image] =>[orig_patent_app_number] => 09965766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6210061 [patent_doc_number] => 20020072531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-13 [patent_title] => 'Antithrombotic agents' [patent_app_type] => new [patent_app_number] => 09/967054 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13501 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20020072531.pdf [firstpage_image] =>[orig_patent_app_number] => 09967054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1343202 [patent_doc_number] => 06586459 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-01 [patent_title] => 'Antithrombotic agents' [patent_app_type] => B2 [patent_app_number] => 09/967203 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13186 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 721 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586459.pdf [firstpage_image] =>[orig_patent_app_number] => 09967203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1319656 [patent_doc_number] => 06605626 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-12 [patent_title] => 'Antithrombotic agents' [patent_app_type] => B2 [patent_app_number] => 09/961164 [patent_app_country] => US [patent_app_date] => 2001-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59998 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605626.pdf [firstpage_image] =>[orig_patent_app_number] => 09961164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1317570 [patent_doc_number] => RE038200 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Indole-2,3-dione-3-oxime derivatives' [patent_app_type] => E1 [patent_app_number] => 09/956892 [patent_app_country] => US [patent_app_date] => 2001-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11295 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/038/RE038200.pdf [firstpage_image] =>[orig_patent_app_number] => 09956892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736098 [patent_doc_number] => 20030013733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine' [patent_app_type] => new [patent_app_number] => 09/960031 [patent_app_country] => US [patent_app_date] => 2001-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28838 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013733.pdf [firstpage_image] =>[orig_patent_app_number] => 09960031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064182 [patent_doc_number] => 20020032187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Method for stimulating bone formation' [patent_app_type] => new [patent_app_number] => 09/956659 [patent_app_country] => US [patent_app_date] => 2001-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28349 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20020032187.pdf [firstpage_image] =>[orig_patent_app_number] => 09956659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745907 [patent_doc_number] => 20030023090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Cocaine receptor binding ligands' [patent_app_type] => new [patent_app_number] => 09/956159 [patent_app_country] => US [patent_app_date] => 2001-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14836 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20030023090.pdf [firstpage_image] =>[orig_patent_app_number] => 09956159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5874660 [patent_doc_number] => 20020049189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Vanadium (IV) complexes containing catecholate ligand and having spermicidal activity' [patent_app_type] => new [patent_app_number] => 09/957524 [patent_app_country] => US [patent_app_date] => 2001-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8364 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20020049189.pdf [firstpage_image] =>[orig_patent_app_number] => 09957524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6082610 [patent_doc_number] => 20020082272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists' [patent_app_type] => new [patent_app_number] => 09/954863 [patent_app_country] => US [patent_app_date] => 2001-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9251 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082272.pdf [firstpage_image] =>[orig_patent_app_number] => 09954863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1418086 [patent_doc_number] => 06518287 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-11 [patent_title] => 'Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists' [patent_app_type] => B2 [patent_app_number] => 09/955380 [patent_app_country] => US [patent_app_date] => 2001-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10260 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518287.pdf [firstpage_image] =>[orig_patent_app_number] => 09955380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1517618 [patent_doc_number] => 06500837 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-31 [patent_title] => 'Fused ring system containing indole as M4 selective aza-anthracene muscarinic receptor antagonists' [patent_app_type] => B2 [patent_app_number] => 09/952735 [patent_app_country] => US [patent_app_date] => 2001-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5543 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500837.pdf [firstpage_image] =>[orig_patent_app_number] => 09952735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6515286 [patent_doc_number] => 20020026057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-28 [patent_title] => 'Method for the crystallisation of a tetrahydropyridin derivative and resulting crystalline forms' [patent_app_type] => new [patent_app_number] => 09/947821 [patent_app_country] => US [patent_app_date] => 2001-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5721 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20020026057.pdf [firstpage_image] =>[orig_patent_app_number] => 09947821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6453021 [patent_doc_number] => 20020177715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-28 [patent_title] => 'Novel autoinducer molecules and uses therefor' [patent_app_type] => new [patent_app_number] => 09/945325 [patent_app_country] => US [patent_app_date] => 2001-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13113 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20020177715.pdf [firstpage_image] =>[orig_patent_app_number] => 09945325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1570548 [patent_doc_number] => 06498166 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-24 [patent_title] => 'Pyrazolopyridines' [patent_app_type] => B1 [patent_app_number] => 09/890925 [patent_app_country] => US [patent_app_date] => 2001-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9666 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/498/06498166.pdf [firstpage_image] =>[orig_patent_app_number] => 09890925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5988080 [patent_doc_number] => 20020099211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => '9-alkylamino-1-nitroacridine derivatives' [patent_app_type] => new [patent_app_number] => 09/934715 [patent_app_country] => US [patent_app_date] => 2001-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9222 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20020099211.pdf [firstpage_image] =>[orig_patent_app_number] => 09934715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6415859 [patent_doc_number] => 20020183520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Process to prepare (5R)-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]-quinolin-2(1H)-one' [patent_app_type] => new [patent_app_number] => 09/934749 [patent_app_country] => US [patent_app_date] => 2001-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4641 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20020183520.pdf [firstpage_image] =>[orig_patent_app_number] => 09934749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1401333 [patent_doc_number] => 06538003 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Pyridopyranoazepine derivatives, their preparation and their therapeutic application' [patent_app_type] => B1 [patent_app_number] => 09/913679 [patent_app_country] => US [patent_app_date] => 2001-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5398 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/538/06538003.pdf [firstpage_image] =>[orig_patent_app_number] => 09913679 [rel_patent_id] =>[rel_patent_doc_number] =>)